IP Verse

Dosing Regimen Associated With Long Acting Injectable Paliperidone Esters

EP2234617

JANSSEN PHARMACEUTICA NV
Application Number
EP08863534A
Filing Date
Dec 17, 2008
Status
Granted And Under Opposition
Feb 26, 2021
Grant Date
Mar 31, 2021
External Links
Slate, Register

Biblio Summary

The patent EP2234617B1 was granted on Mar 31, 2021 by Janssen Pharmaceutica Nv The patent is currently Granted And Under Opposition.

Oppositions Filed by other Companies on the Patent

The table below shows 20 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

EGIS GYOGYSZERGYAR ZARTKORUEN MUKODO RESZVENYTARSASAGDec 31, 2021WITHDRAWN
ZENTIVA K.S.Dec 31, 2021WITHDRAWN
HOFFMANN EITLE SLUDec 30, 2021WITHDRAWN
FARMAPROJECTS S.A.U.Dec 29, 2021WITHDRAWN
GILL JENNINGS & EVERY LLPDec 29, 2021WITHDRAWN
LABORATORIOS LESVI, S.L.Dec 28, 2021WITHDRAWN
SUN PHARMACEUTICAL INDUSTRIES EUROPE B.V.Dec 27, 2021WITHDRAWN
TOLMAR INTERNATIONAL LIMITEDDec 27, 2021WITHDRAWN
BIOGARANDec 23, 2021WITHDRAWN
DF-MP DORRIES FRANK-MOLNIA & POHLMAN PATENTANWALTE RECHTSANWALTE PARG MBBDec 23, 2021WITHDRAWN
ACCORD HEALTHCARE LTDDec 22, 2021WITHDRAWN
EVER VALINJECT GMBHDec 22, 2021WITHDRAWN
HOFFMANN EITLEDec 22, 2021WITHDRAWN
ABBOTT PRODUCTS OPERATIONS AGDec 20, 2021WITHDRAWN
MAIWALD GMBHDec 20, 2021WITHDRAWN
SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETIDec 20, 2021WITHDRAWN
STADADec 17, 2021WITHDRAWN
INSTONE, TERRY/APPLEYARD LEES IP LLP/READ, HOWARDDec 10, 2021WITHDRAWN
ADVANZ PHARMA SERVICES (UK) LTD.Dec 3, 2021WITHDRAWN
TEVAMar 31, 2021WITHDRAWN

More Opposed Patents of Janssen Pharmaceutica Nv

The table below shows the patents of Janssen Pharmaceutica Nv that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP4025188Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJan 10, 20242
EP4025187Dosing Regimens Associated With Extended Release Paliperidone Injectable FormulationsJan 3, 20242
EP3744326Dosing Regimen For Missed Doses For Long-Acting Injectable Paliperidone EstersDec 6, 20239

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.

  • Date

    Description

  • Get instant alerts for new documents